Cross Country Healthcare INC 8-K filings
NASDAQ
Cross Country Healthcare will host a conference call on July 31, 2024, to discuss its second quarter 2024 financial results.
NASDAQ
Cross Country Healthcare will attend the Citizens JMP Medical Devices and Healthcare Services Forum on June 20, 2024, for investor meetings.
NASDAQ
Cross Country Healthcare's stockholders approved a new 2024 Omnibus Incentive Plan at the annual meeting on May 14, 2024, designed to align employee and shareholder interests through various equity-based awards.
NASDAQ
Cross Country Healthcare successfully held its annual meeting, electing directors, ratifying the accounting firm, and approving executive compensation and an incentive plan.
NASDAQ
Cross Country Healthcare will be participating in the William Blair and Jefferies Global Healthcare conferences in June 2024.
NASDAQ
Cross Country Healthcare anticipates a $20 million bad debt charge in the second quarter of 2024 due to a customer's Chapter 11 bankruptcy filing.
NASDAQ
Cross Country Healthcare, Inc. will participate in the Benchmarks Healthcare House Call Virtual Investor Conference on May 21-22, 2024.
NASDAQ
8-K: Cross Country Healthcare Reports First Quarter 2024 Results, Revenue Declines Amid Market Challenges
Cross Country Healthcare's first quarter 2024 results show a significant year-over-year revenue decrease, though the company highlights growth in physician staffing and homecare.
NASDAQ
Cross Country Healthcare will host a conference call on May 1, 2024, to discuss its first quarter 2024 financial results.
NASDAQ
Cross Country Healthcare will attend the Oppenheimer 34th Annual Healthcare Med-Tech & Services Conference in March for investor meetings.
NASDAQ
Cross Country Healthcare's Chief Commercial Officer, Daniel J. White, will depart the company on March 31, 2024, with a separation agreement in place.
NASDAQ
8-K: Cross Country Healthcare Reports Mixed Q4 and Full Year 2023 Results Amidst Market Normalization
Cross Country Healthcare's Q4 2023 results show a significant year-over-year revenue decline, though the company exceeded the high end of its guidance range, while also achieving a record year of cash flow from operations.
NASDAQ
Cross Country Healthcare will host a conference call on February 21, 2024, to discuss its fourth quarter and full year 2023 financial results.